Tech Company Financing Transactions
Newomics Funding Round
MSA Capital, Berkeley Catalyst Fund and LDV Partners invested in a $7.9 million Series B capital raise for Newomics. The round was announced on 12/2/2020.
Transaction Overview
Company Name
Announced On
12/2/2020
Transaction Type
Venture Equity
Amount
$7,900,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
804 Heinz Ave. 150
Berkeley, CA 94710
USA
Berkeley, CA 94710
USA
Phone
Website
Email Address
Overview
Newomics Inc. is dedicated to creating and commercializing innovative (New) and integrative (Omics) platforms and solutions for precision medicine. Our initial M3 emitter product line enables unprecedented gains in sensitivity, throughput, and robustness for liquid chromatography -- mass spectrometry (LC-MS).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daojing Wang
Browse more venture capital transactions:
Prev: 12/2/2020: Tallac Therapeutics venture capital transaction
Next: 12/2/2020: Deduce venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs